NCT06909292View on ClinicalTrials.gov

Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1

RecruitingOBSERVATIONAL
Enrollment

180

Participants

Timeline

Start Date

April 3, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

June 30, 2027

Conditions
Sacroiliac Joint Dysfunction
Interventions
DEVICE

Sacroiliac Joint transfixing and fusion system (Nevro1)

The Nevro1 is a titanium cage the is implanted in the sacroiliac join from a posterior direction, and then anchors are deployed that stabilize the joint. It has multiple openings to allow surgeons to fill them with autogenous bone graft to encourage bone bridging through the implant for SIJ fusion.

Trial Locations (5)

27103

RECRUITING

Carolinas Pain Institute, Winston-Salem

48033

NOT_YET_RECRUITING

Michigan Orthopaedic Surgeons, Southfield

77380

RECRUITING

Advanced Spine and Pain Specialists, Spring

77384

RECRUITING

Procura Pain and Spine, The Woodlands

95240

RECRUITING

AIRS Clinic, Lodi

All Listed Sponsors
lead

Nevro Corp

INDUSTRY

NCT06909292 - Sacroiliac (SI) Joint Transfixing and Fusion: Meaningful Long Term Outcomes With Nevro1 | Biotech Hunter | Biotech Hunter